‘Doctor Strange In The Multiverse Of Madness’ To Beguile Start Of Summer With $300M Global Opening
04.05.2022 - 03:05
/ deadline.com
Happy times are here again for movie theaters this weekend with Disney/Marvel’s long-awaited Doctor Strange in the Multiverse of Madness set to fire up the summer box office season we didn’t have a year ago.
The movie, which fans are anticipating to be a three-prong sequel to previous Marvel blockbuster Spider-Man: No Way Home (which teed up events with the Benedict Cumberbatch character) and Disney+ series WandaVision and Loki is now eyeing a $160M-$180M domestic start in what is the widest release ever during the pandemic era at 4,400 theaters, plus another $140M+ overseas.
That will yield at least a $300M worldwide start, which will rep the second best box office debut of the Covid era after No Way Home‘s $582M WW, and ahead of The Batman‘s $251M WW. Similar to Batman, Dr. Strange 2 won’t have Russia and China in its offshore bookings. In addition, most of the Middle East isn’t playing the Marvel sorcerer given LBGTQ elements in the pic.
Dr. Strange 2 currently sits at 79% fresh off 115 reviews on Rotten Tomatoes to No Way Home‘s 93% certified fresh from 410 reviews, and the question heading into the weekend is how much will this byzantine tale overindex. Does it play strictly to the Marvel fans, or will it rally the unfaithful? Elizabeth Olsen’s Wanda Maximoff is seen as a plus in regards to attracting a potentially younger female demo than usual for an MCU title.
Another selling point for the core fanbase: The sequel reps the return of Sam Raimi to the MCU, his last time in the directing chair being for Sony’s original Spider-Man trilogy of 2002-2007.
Currently, Dr. Strange 2 U.S./Canada presales stand at $60M, which is ahead of Warner Bros.’ The Batman‘s $42M at the same point in time before its opening back in March,
The website popstar.one is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can
send a complaint on the news if you find it unreliable.